Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
37.9 EUR | -0.33% |
|
+1.54% | -18.24% |
01:57pm | Redburn Atlantic Adjusts Price Target on Bristol-Myers Squibb to $50 From $54, Maintains Neutral Rating | MT |
Jul. 10 | Barclays Adjusts Price Target on Bristol-Myers Squibb to $41 From $43 | MT |
Official Publications
SEC Filing 8K | CO | |
SEC Filing 10Q-1 | CO | |
Slide show Q1 | CO | |
1st quarter results | CO | |
SEC Filing 8K | CO | |
Proxy Statments | CO | |
SEC Filing 4K | CO | |
SEC Filing 8K | CO | |
SEC Filing 10K | CO | |
Slide show results | CO | |
Annual results | CO | |
SEC Filing 8K | CO | |
Dividends | CO | |
SEC Filing 10Q-3 | CO | |
Slide show Q3 | CO | |
3rd quarter results | CO | |
SEC Filing 8K | CO | |
SEC Filing 4K | CO | |
SEC Filing 8K | CO | |
Slide show half-year results | CO | |
1st-half-year results | CO | |
SEC Filing 10Q-2 | CO | |
SEC Filing 8K | CO | |
SEC Filing 8K | CO | |
SEC Filing 4K | CO |
- Stock Market
- Equities
- BMY Stock
- BRM Stock
- News Bristol-Myers Squibb Company
- Official Publications